Authors:
CHOC MG
MUELLER EA
ROBINSON WT
KUMLE A
SMITH HT
CHARNICK SB
Citation: Mg. Choc et al., RELATIVE BIOAVAILABILITY OF NEORAL VERSUS SANDIMMUNE IN THE PRESENCE OF A P450IIIA AND P-GLYCOPROTEIN INHIBITOR, Transplantation proceedings, 30(5), 1998, pp. 1664-1665
Authors:
CHARNICK SB
FRACASSO P
EGORIN M
SONNEVELD P
BLEEHAN N
GIACCONE G
NIEDERBERGER W
SMITH HT
PEARCE T
SIKIC BI
Citation: Sb. Charnick et al., PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF SDZ PSC-833, A NOVEL MULTIDRUG-RESISTANCE REVERSING AGENT, IN PHASE-1 TRIALS WITH CHEMOTHERAPEUTIC-AGENTS, European journal of cancer, 33, 1997, pp. 775-775
Authors:
GUBBINS EJ
POHLMAN KL
LEE JA
SMITH HT
PARRY JM
SIMMER RL
Citation: Ej. Gubbins et al., THE UNIVERSAL CLONING SITE SYSTEM FOR DESIGNING GENE-EXPRESSION CASSETTES AND VECTORS, Protein engineering, 10, 1997, pp. 27-27
Citation: Ja. Rodgers et Ht. Smith, BUFFER ZONE DISTANCES TO PROTECT FORAGING AND LEAFING WATERBIRDS FROMHUMAN DISTURBANCE IN FLORIDA, Wildlife Society bulletin, 25(1), 1997, pp. 139-145
Authors:
LUSH RM
MEADOWS B
FOJO AT
KALAFSKY G
SMITH HT
BATES S
FIGG WD
Citation: Rm. Lush et al., INITIAL PHARMACOKINETICS AND BIOAVAILABILITY OF PSC-833, A P-GLYCOPROTEIN ANTAGONIST, Journal of clinical pharmacology, 37(2), 1997, pp. 123-128
Authors:
DUNN S
COONEY G
SOMMERAUER J
LINDSAY C
MCDIARMID S
WONG RL
CHANG CT
SMITH HT
CHOC MG
Citation: S. Dunn et al., PHARMACOKINETICS OF AN ORAL SOLUTION OF THE MICROEMULSION FORMULATIONOF CYCLOSPORINE IN MAINTENANCE PEDIATRIC LIVER-TRANSPLANT RECIPIENTS, Transplantation, 63(12), 1997, pp. 1762-1767
Citation: Ht. Smith et Hn. Shirk, THE PERILS OF DEFECTIVE DOCUMENTATION - PREPARING BUSINESS AND TECHNICAL COMMUNICATORS TO AVOID PRODUCTS-LIABILITY, Journal of business and technical communication, 10(2), 1996, pp. 187-202
Citation: Ja. Rodgers et Ht. Smith, SET-BACK DISTANCES TO PROTECT NESTING BIRD COLONIES FROM HUMAN DISTURBANCE IN FLORIDA, Conservation biology, 9(1), 1995, pp. 89-99
Authors:
KOVARIK JM
MUELLER EA
KALLAY Z
SMITH HT
LISON AE
ARNS W
RENNER E
Citation: Jm. Kovarik et al., CONCENTRATION-GUIDED STRATEGIES IN DRUG DEVELOPMENT - EXPERIENCE WITHA CYCLOSPORINE ANALOG IN TRANSPLANTATION, Journal of clinical pharmacology, 35(12), 1995, pp. 1136-1143
Authors:
SMITH HT
JOKUBAITIS LA
TROENDLE AJ
HWANG DS
ROBINSON WT
Citation: Ht. Smith et al., PHARMACOKINETICS OF FLUVASTATIN AND SPECIFIC DRUG-INTERACTIONS, American journal of hypertension, 6(11), 1993, pp. 190000375-190000382
Citation: G. Kalafsky et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF FLUVASTATIN IN HUMAN PLASMA, Journal of chromatography. Biomedical applications, 614(2), 1993, pp. 307-313